Zheng Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zheng Zhou has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Wansheng Chen
The SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica Shanghai University of Traditional Chinese Medicine Shanghai 201203 China
4 shared publications - Lei Zhang
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
3 shared publications Qing Li
Department of Pharmacy, Changzheng Hospital Second Military Medical University Shanghai China
3 shared publicationsYun Wang
Biomedical Innovation R&D Center, School of Medicine Shanghai University Shanghai China
3 shared publicationsCuicui Han
College of Food Science and Technology, Shanghai Ocean University, 201306 Shanghai, China
2 shared publications- Qing Li
Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, 200003 Shanghai, China
2 shared publications
Latest Publications
- 5 November 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 27
Identification of Candidate Targets and Immune Characteristics of Salvianolic Acid E Against Ulcerative Colitis via Integrative Transcriptomic Analysis and Machine Learning
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex pathogenesis. This study aims to systematically investigate the mechanism of Salvianolic acid E (SAE) in treating UC by identifying its core molecular targets. Methods: Potential target genes of SAE against UC were screened via differential expression analysis of datasets. Integrated approaches including machine learning algorithms, network pharmacology, molecular docking, immune infiltration analysis, and experimental validation were employed to investigate the binding interactions between SAE and target proteins. Results: A total of 13 potential target genes were identified. Machine learning further refined these to five core genes (SLC23A1, SLC6A14, LCN2, PLA2G2A, and CASP1) as key regulatory factors. Among them, SLC23A1 was significantly downregulated, whereas the other four were significantly upregulated. Molecular docking showed putative interactions between SAE and the target proteins. Immune infiltration analysis revealed strong correlations between the core genes and immune cells such as M2 macrophages, neutrophils, and resting mast cells. Cellular-level validation confirmed the expression patterns of these key genes. Discussion: These five core genes constitute a coordinated pathological axis underlying UC progression, which sequentially involves impaired epithelial barrier function, activated innate immune response, amplified pro-inflammatory lipid signaling, and caspase-1-mediated pyroptosis. The stable binding of SAE to these target proteins supports a multi-target synergistic mechanism: SAE may concurrently correct dysregulated solute transport, suppress pro-inflammatory enzymatic activities, and modulate the colonic immune microenvironment. In particular, the strong associations of core genes with neutrophils, M2 macrophages, and resting mast cells suggest that immunomodulation may serve as a critical potential dimension of SAE’s therapeutic efficacy against UC. Our integrated analytical strategy also provides a replicable paradigm for deciphering the pharmacological mechanisms of multi-target natural compounds. Conclusion: The five candidate regulatory genes and the putative binding of SAE to its key targets provide critical insights into the therapeutic mechanism of SAE in UC, offering novel directions for future UC treatment development.
- 5 November 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 27
Identification of Candidate Targets and Immune Characteristics of Salvianolic Acid E Against Ulcerative Colitis via Integrative Transcriptomic Analysis and Machine Learning
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex pathogenesis. This study aims to systematically investigate the mechanism of Salvianolic acid E (SAE) in treating UC by identifying its core molecular targets. Methods: Potential target genes of SAE against UC were screened via differential expression analysis of datasets. Integrated approaches including machine learning algorithms, network pharmacology, molecular docking, immune infiltration analysis, and experimental validation were employed to investigate the binding interactions between SAE and target proteins. Results: A total of 13 potential target genes were identified. Machine learning further refined these to five core genes (SLC23A1, SLC6A14, LCN2, PLA2G2A, and CASP1) as key regulatory factors. Among them, SLC23A1 was significantly downregulated, whereas the other four were significantly upregulated. Molecular docking showed putative interactions between SAE and the target proteins. Immune infiltration analysis revealed strong correlations between the core genes and immune cells such as M2 macrophages, neutrophils, and resting mast cells. Cellular-level validation confirmed the expression patterns of these key genes. Discussion: These five core genes constitute a coordinated pathological axis underlying UC progression, which sequentially involves impaired epithelial barrier function, activated innate immune response, amplified pro-inflammatory lipid signaling, and caspase-1-mediated pyroptosis. The stable binding of SAE to these target proteins supports a multi-target synergistic mechanism: SAE may concurrently correct dysregulated solute transport, suppress pro-inflammatory enzymatic activities, and modulate the colonic immune microenvironment. In particular, the strong associations of core genes with neutrophils, M2 macrophages, and resting mast cells suggest that immunomodulation may serve as a critical potential dimension of SAE’s therapeutic efficacy against UC. Our integrated analytical strategy also provides a replicable paradigm for deciphering the pharmacological mechanisms of multi-target natural compounds. Conclusion: The five candidate regulatory genes and the putative binding of SAE to its key targets provide critical insights into the therapeutic mechanism of SAE in UC, offering novel directions for future UC treatment development.
- Open Access
- 29 June 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (6) , 50834
Transcriptomic Insights Into Brassinolide-Mediated Control of Bioactive Compound Biosynthesis in Salvia miltiorrhiza Bunge
Background:Brassinolide (BR) plays a pivotal role in regulating plant secondary metabolism and can promote the accumulation of bioactive compounds. However, relatively few studies have explored the application of BR in Salvia miltiorrhiza, and the mechanistic basis for its function in this context remains poorly understood.Methods:In this study, S. miltiorrhiza hairy roots were treated with BR at 1 μM and 5 μM. The treated samples were analyzed via high-performance liquid chromatography (HPLC)-based chemical quantification, transcriptomic sequencing, and quantitative real-time polymerase chain reaction (qRT-PCR) validation to systematically elucidate the concentration-dependent and time-dependent molecular mechanisms underlying BR-mediated biosynthesis of tanshinones and salvianolic acids in S. miltiorrhiza.Results:BR treatment at the 1 μM dose level significantly induced the accumulation of rosmarinic acid, salvianolic acid B, and tanshinone IIA, with respective 1.43, 1.82, and 1.78-fold increases in the levels of these compounds compared to controls. Expression of most key biosynthetic genes involved in the salvianolic acid and tanshinone biosynthesis pathways peaked at 1 h after treatment with 1 μM BR. Further transcriptomic analysis identified 15 significantly upregulated transcription factors that may regulate tanshinone and salvianolic acid biosynthesis. These differentially expressed genes were primarily enriched in the phenylpropanoid and terpenoid pathways. qRT-PCR validation confirmed the consistency and reliability of these transcriptomic data.Conclusion:Collectively, these findings reveal that BR treatment enhances secondary metabolism in S. miltiorrhiza by orchestrating changes in the expression of key structural genes and transcription factors, providing a theoretical basis for the breeding of high-quality germplasm resources.
- 29 June 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (6) , 50834
Open AccessTranscriptomic Insights Into Brassinolide-Mediated Control of Bioactive Compound Biosynthesis in Salvia miltiorrhiza Bunge
Background:Brassinolide (BR) plays a pivotal role in regulating plant secondary metabolism and can promote the accumulation of bioactive compounds. However, relatively few studies have explored the application of BR in Salvia miltiorrhiza, and the mechanistic basis for its function in this context remains poorly understood.Methods:In this study, S. miltiorrhiza hairy roots were treated with BR at 1 μM and 5 μM. The treated samples were analyzed via high-performance liquid chromatography (HPLC)-based chemical quantification, transcriptomic sequencing, and quantitative real-time polymerase chain reaction (qRT-PCR) validation to systematically elucidate the concentration-dependent and time-dependent molecular mechanisms underlying BR-mediated biosynthesis of tanshinones and salvianolic acids in S. miltiorrhiza.Results:BR treatment at the 1 μM dose level significantly induced the accumulation of rosmarinic acid, salvianolic acid B, and tanshinone IIA, with respective 1.43, 1.82, and 1.78-fold increases in the levels of these compounds compared to controls. Expression of most key biosynthetic genes involved in the salvianolic acid and tanshinone biosynthesis pathways peaked at 1 h after treatment with 1 μM BR. Further transcriptomic analysis identified 15 significantly upregulated transcription factors that may regulate tanshinone and salvianolic acid biosynthesis. These differentially expressed genes were primarily enriched in the phenylpropanoid and terpenoid pathways. qRT-PCR validation confirmed the consistency and reliability of these transcriptomic data.Conclusion:Collectively, these findings reveal that BR treatment enhances secondary metabolism in S. miltiorrhiza by orchestrating changes in the expression of key structural genes and transcription factors, providing a theoretical basis for the breeding of high-quality germplasm resources.
- 22 November 2024
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 67 (1) , 135-149
The ABC transporter SmABCG1 mediates tanshinones export from the peridermic cells of Salvia miltiorrhiza root
Plants have mechanisms to transport secondary metabolites from where they are biosynthesized to the sites where they function, or to sites such as the vacuole for detoxification. However, current research has mainly focused on metabolite biosynthesis and regulation, and little is known about their transport. Tanshinone, a class diterpenoid with medicinal properties, is biosynthesized in the periderm of Salvia miltiorrhiza roots. Here, we discovered that tanshinone can be transported out of peridermal cells and secreted into the soil environment and that the ABC transporter SmABCG1 is involved in the efflux of tanshinone ⅡA and tanshinone Ⅰ. The SmABCG1 gene is adjacent to the diterpene biosynthesis gene cluster in the S. miltiorrhiza genome. The temporal–spatial expression pattern of SmABCG1 is consistent with tanshinone accumulation profiles. SmABCG1 is located on the plasma membrane and preferentially accumulates in the peridermal cells of S. miltiorrhiza roots. Heterologous expression in Xenopus laevis oocytes demonstrated that SmABCG1 can export tanshinone ⅡA and tanshinone Ⅰ. CRISPR/Cas9‐mediated mutagenesis of SmABCG1 in S. miltiorrhiza hairy roots resulted in a significant decrease in tanshinone contents in both hairy roots and the culture medium, whereas overexpression of this gene resulted in increased tanshinone contents. CYP76AH3 transcript levels increased in hairy roots overexpressing SmABCG1 and decreased in knockout lines, suggesting that SmABCG1 may affect the expression of CYP76AH3, indirectly regulating tanshinone biosynthesis. Finally, tanshinone ⅡA showed cytotoxicity to Arabidopsis roots. These findings offer new perspectives on plant diterpenoid transport and provide a new genetic tool for metabolic engineering and synthetic biology research.
- 22 November 2024
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 67 (1) , 135-149
The ABC transporter SmABCG1 mediates tanshinones export from the peridermic cells of Salvia miltiorrhiza root
Plants have mechanisms to transport secondary metabolites from where they are biosynthesized to the sites where they function, or to sites such as the vacuole for detoxification. However, current research has mainly focused on metabolite biosynthesis and regulation, and little is known about their transport. Tanshinone, a class diterpenoid with medicinal properties, is biosynthesized in the periderm of Salvia miltiorrhiza roots. Here, we discovered that tanshinone can be transported out of peridermal cells and secreted into the soil environment and that the ABC transporter SmABCG1 is involved in the efflux of tanshinone ⅡA and tanshinone Ⅰ. The SmABCG1 gene is adjacent to the diterpene biosynthesis gene cluster in the S. miltiorrhiza genome. The temporal–spatial expression pattern of SmABCG1 is consistent with tanshinone accumulation profiles. SmABCG1 is located on the plasma membrane and preferentially accumulates in the peridermal cells of S. miltiorrhiza roots. Heterologous expression in Xenopus laevis oocytes demonstrated that SmABCG1 can export tanshinone ⅡA and tanshinone Ⅰ. CRISPR/Cas9‐mediated mutagenesis of SmABCG1 in S. miltiorrhiza hairy roots resulted in a significant decrease in tanshinone contents in both hairy roots and the culture medium, whereas overexpression of this gene resulted in increased tanshinone contents. CYP76AH3 transcript levels increased in hairy roots overexpressing SmABCG1 and decreased in knockout lines, suggesting that SmABCG1 may affect the expression of CYP76AH3, indirectly regulating tanshinone biosynthesis. Finally, tanshinone ⅡA showed cytotoxicity to Arabidopsis roots. These findings offer new perspectives on plant diterpenoid transport and provide a new genetic tool for metabolic engineering and synthetic biology research.
- Open Access
- 16 January 2024
- Published by Wiley in Plant Biotechnology Journal
- Vol. 22 (6) , 1536-1548
Versatile CYP98A enzymes catalyse meta‐hydroxylation reveals diversity of salvianolic acids biosynthesis
Summary: Salvianolic acids (SA), such as rosmarinic acid (RA), danshensu (DSS), and their derivative salvianolic acid B (SAB), etc. widely existed in Lamiaceae and Boraginaceae families, are of interest due to medicinal properties in the pharmaceutical industries. Hundreds of studies in past decades described that 4‐coumaroyl‐CoA and 4‐hydroxyphenyllactic acid (4‐HPL) are common substrates to biosynthesize SA with participation of rosmarinic acid synthase (RAS) and cytochrome P450 98A (CYP98A) subfamily enzymes in different plants. However, in our recent study, several acyl donors and acceptors included DSS as well as their ester‐forming products all were determined in SA‐rich plants, which indicated that previous recognition to SA biosynthesis is insufficient. Here, we used Salvia miltiorrhiza, a representative important medicinal plant rich in SA, to elucidate the diversity of SA biosynthesis. Various acyl donors as well as acceptors are catalysed by SmRAS to form precursors of RA and two SmCYP98A family members, SmCYP98A14 and SmCYP98A75, are responsible for different positions' meta‐hydroxylation of these precursors. SmCYP98A75 preferentially catalyses C‐3′ hydroxylation, and SmCYP98A14 preferentially catalyses C‐3 hydroxylation in RA generation. In addition, relative to C‐3′ hydroxylation of the acyl acceptor moiety in RA biosynthesis, SmCYP98A75 has been verified as the first enzyme that participates in DSS formation. Furthermore, SmCYP98A enzymes knockout resulted in the decrease and overexpression leaded to dramatic increase of SA accumlation. Our study provides new insights into SA biosynthesis diversity in SA‐abundant species and versatility of CYP98A enzymes catalytic preference in meta‐hydroxylation reactions. Moreover, CYP98A enzymes are ideal metabolic engineering targets to elevate SA content.
- 16 January 2024
- Published by Wiley in Plant Biotechnology Journal
- Vol. 22 (6) , 1536-1548
Open AccessVersatile CYP98A enzymes catalyse meta‐hydroxylation reveals diversity of salvianolic acids biosynthesis
Summary: Salvianolic acids (SA), such as rosmarinic acid (RA), danshensu (DSS), and their derivative salvianolic acid B (SAB), etc. widely existed in Lamiaceae and Boraginaceae families, are of interest due to medicinal properties in the pharmaceutical industries. Hundreds of studies in past decades described that 4‐coumaroyl‐CoA and 4‐hydroxyphenyllactic acid (4‐HPL) are common substrates to biosynthesize SA with participation of rosmarinic acid synthase (RAS) and cytochrome P450 98A (CYP98A) subfamily enzymes in different plants. However, in our recent study, several acyl donors and acceptors included DSS as well as their ester‐forming products all were determined in SA‐rich plants, which indicated that previous recognition to SA biosynthesis is insufficient. Here, we used Salvia miltiorrhiza, a representative important medicinal plant rich in SA, to elucidate the diversity of SA biosynthesis. Various acyl donors as well as acceptors are catalysed by SmRAS to form precursors of RA and two SmCYP98A family members, SmCYP98A14 and SmCYP98A75, are responsible for different positions' meta‐hydroxylation of these precursors. SmCYP98A75 preferentially catalyses C‐3′ hydroxylation, and SmCYP98A14 preferentially catalyses C‐3 hydroxylation in RA generation. In addition, relative to C‐3′ hydroxylation of the acyl acceptor moiety in RA biosynthesis, SmCYP98A75 has been verified as the first enzyme that participates in DSS formation. Furthermore, SmCYP98A enzymes knockout resulted in the decrease and overexpression leaded to dramatic increase of SA accumlation. Our study provides new insights into SA biosynthesis diversity in SA‐abundant species and versatility of CYP98A enzymes catalytic preference in meta‐hydroxylation reactions. Moreover, CYP98A enzymes are ideal metabolic engineering targets to elevate SA content.
- Open Access
LACCASE is Necessary for Root Development in Salvia miltiorrhiza
Laccases are multicopper-containing glycoproteins related to monolignol oxidation and polymerization. These properties indicate that laccases are involved in the formation of important medicinal phenolic acid compounds in Salvia miltiorrhiza such as salvianolic acid B (SAB), which is used for cardiovascular disease treatment. To date, 29 laccases have been found in S. miltiorrhiza , some of which influence the synthesis of phenolic acids. Because of the functional redundancy of laccase genes, their roles in S. miltiorrhiza are poorly understood. In this study, the CRISPR/Cas9 system was first used for dual gene locus targeting in S. miltiorrhiza to knock out multiple laccase family genes. The development of the roots was retarded, and root microstructure was abnormal in laccase mutant lines. Additionally, the accumulation of phenolic acid compounds as well as lignin was dramatically reduced. This study suggests that SmLACs are necessary for root development and phenolic acid compound metabolism in S. miltiorrhiza .
Open AccessLACCASE is Necessary for Root Development in Salvia miltiorrhiza
Laccases are multicopper-containing glycoproteins related to monolignol oxidation and polymerization. These properties indicate that laccases are involved in the formation of important medicinal phenolic acid compounds in Salvia miltiorrhiza such as salvianolic acid B (SAB), which is used for cardiovascular disease treatment. To date, 29 laccases have been found in S. miltiorrhiza , some of which influence the synthesis of phenolic acids. Because of the functional redundancy of laccase genes, their roles in S. miltiorrhiza are poorly understood. In this study, the CRISPR/Cas9 system was first used for dual gene locus targeting in S. miltiorrhiza to knock out multiple laccase family genes. The development of the roots was retarded, and root microstructure was abnormal in laccase mutant lines. Additionally, the accumulation of phenolic acid compounds as well as lignin was dramatically reduced. This study suggests that SmLACs are necessary for root development and phenolic acid compound metabolism in S. miltiorrhiza .
- 26 June 2020
- Published by Wiley in New Phytologist
- Vol. 228 (3) , 932-945
TRICHOME AND ARTEMISININ REGULATOR 2 positively regulates trichome development and artemisinin biosynthesis in Artemisia annua
Summary: Glandular secretory trichomes (GSTs) are regarded as biofactories for synthesizing, storing, and secreting artemisinin. It is necessary to figure out the initiation and development regulatory mechanism of GSTs to cultivate high‐yielding Artemisia annua. Here, we identified an MYB transcription factor, AaTAR2, from bioinformatics analysis of the A. annua genome database and Arabidopsis trichome development‐related genes. AaTAR2 is mainly expressed in young leaves and located in the nucleus. Repression and overexpression of AaTAR2 resulted in a decrease and increase, respectively, in the GSTs numbers, leaf biomass, and the artemisinin content in transgenic plants. Furthermore, the morphological characteristics changed obviously in trichomes, suggesting AaTAR2 plays a key role in trichome formation. In addition, the expression of flavonoid biosynthesis genes and total flavonoid content increased dramatically in AaTAR2‐overexpressing transgenic plants. Owing to flavonoids possibly counteracting emerging resistance to artemisinin in Plasmodium species, AaTAR2 is a potential target to improve the effect of artemisinin in clinical therapy. Taken together, AaTAR2 positively regulates trichome development and artemisinin and flavonoid biosynthesis. A better understanding of this ‘multiple functions’ transcription factor may enable enhanced artemisinin and flavonoids yield. AaTAR2 is a potential breeding target for cultivating high‐quality A. annua.
- 26 June 2020
- Published by Wiley in New Phytologist
- Vol. 228 (3) , 932-945
TRICHOME AND ARTEMISININ REGULATOR 2 positively regulates trichome development and artemisinin biosynthesis in Artemisia annua
Summary: Glandular secretory trichomes (GSTs) are regarded as biofactories for synthesizing, storing, and secreting artemisinin. It is necessary to figure out the initiation and development regulatory mechanism of GSTs to cultivate high‐yielding Artemisia annua. Here, we identified an MYB transcription factor, AaTAR2, from bioinformatics analysis of the A. annua genome database and Arabidopsis trichome development‐related genes. AaTAR2 is mainly expressed in young leaves and located in the nucleus. Repression and overexpression of AaTAR2 resulted in a decrease and increase, respectively, in the GSTs numbers, leaf biomass, and the artemisinin content in transgenic plants. Furthermore, the morphological characteristics changed obviously in trichomes, suggesting AaTAR2 plays a key role in trichome formation. In addition, the expression of flavonoid biosynthesis genes and total flavonoid content increased dramatically in AaTAR2‐overexpressing transgenic plants. Owing to flavonoids possibly counteracting emerging resistance to artemisinin in Plasmodium species, AaTAR2 is a potential target to improve the effect of artemisinin in clinical therapy. Taken together, AaTAR2 positively regulates trichome development and artemisinin and flavonoid biosynthesis. A better understanding of this ‘multiple functions’ transcription factor may enable enhanced artemisinin and flavonoids yield. AaTAR2 is a potential breeding target for cultivating high‐quality A. annua.